Biblio

Found 9 results
Filters: Keyword is Neovascularization, Pathologic  [Clear All Filters]
2015
Cole SW, Nagaraja AS, Lutgendorf SK, Green PA, Sood AK.  2015.  Sympathetic nervous system regulation of the tumour microenvironment.. Nat Rev Cancer. 15(9):563-72.
2013
Moreno-Smith M, Lee SJoo, Lu C, Nagaraja AS, He G, Rupaimoole R, Han HDong, Jennings NB, Roh J-W, Nishimura M et al..  2013.  Biologic effects of dopamine on tumor vasculature in ovarian carcinoma.. Neoplasia. 15(5):502-10.
Le CP, Karnezis T, Achen MG, Stacker SA, Sloan EK.  2013.  Lymphovascular and neural regulation of metastasis: shared tumour signalling pathways and novel therapeutic approaches.. Best Pract Res Clin Anaesthesiol. 27(4):409-25.
Armaiz-Pena GN, Cole SW, Lutgendorf SK, Sood AK.  2013.  Neuroendocrine influences on cancer progression.. Brain Behav Immun. 30 Suppl:S19-25.
2011
Moreno-Smith M, Lu C, Shahzad MMK, Pena GNArmaiz, Allen JK, Stone RL, Mangala LS, Han HDong, Kim HSun, Farley D et al..  2011.  Dopamine blocks stress-mediated ovarian carcinoma growth.. Clin Cancer Res. 17(11):3649-59.
2009
Lee J-W, Shahzad MMK, Lin YG, Armaiz-Pena G, Mangala LS, Han H-D, Kim H-S, Nam EJi, Jennings NB, Halder J et al..  2009.  Surgical stress promotes tumor growth in ovarian carcinoma.. Clin Cancer Res. 15(8):2695-702.
2007
Nilsson MB, Armaiz-Pena G, Takahashi R, Lin YG, Trevino J, Li Y, Jennings N, Arevalo J, Lutgendorf SK, Gallick GE et al..  2007.  Stress hormones regulate interleukin-6 expression by human ovarian carcinoma cells through a Src-dependent mechanism.. J Biol Chem. 282(41):29919-26.
2006
Thaker PH, Han LY, Kamat AA, Arevalo JM, Takahashi R, Lu C, Jennings NB, Armaiz-Pena G, Bankson JA, Ravoori M et al..  2006.  Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma.. Nat Med. 12(8):939-44.
Halder J, Kamat AA, Landen CN, Han LY, Lutgendorf SK, Lin YG, Merritt WM, Jennings NB, Chavez-Reyes A, Coleman RL et al..  2006.  Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy.. Clin Cancer Res. 12(16):4916-24.